Pulmonary Embolism
📧 Sign up to get email alerts when something new happens for Pulmonary Embolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Crux Biomedical Vena Cava Filter Study - United States [Phase 3]
A Phase 3 clinical trial evaluating Crux Biomedical's vena cava filter for preventing pulmonary embolism has completed in the United States.
-
FDA approval · 2014-06-23FDA Approved: ENOXAPARIN SODIUM — Original Application (Italfarmaco SpA)
FDA approved the original application for ENOXAPARIN SODIUM (enoxaparin sodium) submitted by Italfarmaco SpA under an ANDA. The approval con…
-
FDA approval · 2014-06-12FDA Approved: HEPARIN SODIUM — Original Application (Sandoz Inc.)
FDA approved Sandoz Inc.'s original application for generic heparin sodium, an injectable anticoagulant used to prevent and treat thrombotic…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique
This clinical trial update discusses CT dose-reduction using sequential or fast-pitch spiral techniques, and indicates the trial has complet…
-
FDA approval · 2014-05-29FDA Approved: HEPARIN SODIUM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Heparin Sodium (Hospira, Inc.), updating the approved generic product under the ANDA program.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness [Phase 3]
A Phase 3 study evaluating apixaban for the prevention of thrombosis-related events in patients with acute medical illness has completed and…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) [Phase 3]
A Phase 3 trial update (ADVANCE-3) reports results from an investigational drug intended to prevent thrombosis after hip replacement. The st…
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery [Phase 3]
A Phase 3 trial evaluating an investigational drug to prevent thrombosis-related events after knee replacement has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism [Phase 3]
Phase 3 study results report the efficacy and safety of apixaban for treating deep vein thrombosis or pulmonary embolism.
-
CLINICAL_TRIALS withdrawal · 2014-03-20Clinical Trial Update: Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II [Phase 3]
A Phase 3 trial evaluating prolongation of the interval between prothrombin time tests in stable patients with atrial fibrillation and valvu…
-
FDA approval · 2014-03-19FDA Approved: FONDAPARINUX SODIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental ANDA for Fondaparinux sodium from Dr. Reddy's Laboratories Limited, authorizing the generic product to be market…
-
FDA approval · 2014-03-06FDA Approved: XARELTO — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for XARELTO (rivaroxaban) submitted by Janssen Pharmaceuticals, Inc. This action approves changes re…
-
CLINICAL_TRIALS research · 2014-02-27Clinical Trial Update: Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China
An epidemiological study in China is evaluating the long-term risk of adverse events after pulmonary embolism, in the context of chronic thr…
-
CLINICAL_TRIALS research · 2014-02-25Clinical Trial Update: Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins
This entry reports a completed clinical trial assessing whether concurrent use of Warfarin and cephalosporins prolongs the international nor…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Prognostic Value of Plasma Lactate Levels Among Patients With Acute Pulmonary Embolism
The trial evaluated whether plasma lactate levels have prognostic value in patients with acute pulmonary embolism. Findings could help with …
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism [Phase 4]
This document provides an update on a Phase 4 trial evaluating low-dose prolonged infusion of tissue plasminogen activator (tPA) for massive…
-
FDA approval · 2013-11-15FDA Approved: ARIXTRA — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for ARIXTRA (fondaparinux sodium) submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: Evolution of Pulmonary Capillary Blood Volume
This clinical trial (NCT00941187) evaluated changes in pulmonary capillary blood volume in patients with pulmonary embolism. The study statu…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism [Phase 3]
Phase 3 study evaluating the efficacy and safety of apixaban for extended treatment of deep vein thrombosis or pulmonary embolism; results p…
-
FDA approval · 2013-10-22FDA Approved: FRAGMIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA page indicates Pfizer's supplemental application for FRAGMIN (dalteparin sodium) under NDA 020287 is under consideration for a supplemen…
-
CLINICAL_TRIALS trial_result · 2013-10-09Clinical Trial Update: Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients [Phase 4]
Clinical trial update describes Phase 4 evaluation of pharmacogenetics-guided warfarin dosing in Chinese patients.
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism [Phase 4]
This clinical trial update compares safety of low-molecular-weight heparin versus unfractionated heparin when used with thrombolysis for acu…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Evaluation of Contrast Medium Enhanced Post-mortem CT in Virtual Autopsy
This completed trial evaluated contrast-enhanced post-mortem CT imaging for virtual autopsy to assess thromboembolism and vascular condition…
-
FDA approval · 2013-09-12FDA Approved: ARIXTRA — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for ARIXTRA (fondaparinux sodium) submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information [NA]
This completed clinical trial aimed to develop a nomogram that incorporates clinical and genetic information to predict outcomes, focusing o…